| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.00018 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.00019 | 1 |